Gilman Callsen

Gilman is the CEO of Rho Impact and a founder and the former CTO of Rho Impact’s predecessor, Rho AI. With over 15 years of experience building and scaling technology companies, Gilman has been influential in integrating data science, software engineering, and cloud infrastructure to help organizations solve the world’s most complex challenges.

Prior to founding Rho AI, Gilman co-founded MC10 (acquired by Medidata), which developed stretachable, flexible electronics primarily for medical applications. Before MC10, he founded his first company while in college, licensing electrochromic polymer technology for applications in improving building energy efficiency. Gilman holds a BA from Yale University and has guest lectured at Columbia University where he explores the intersection of software engineering and data science when applied to real-world applications.